544205 — National Peroxide Income Statement
0.000.00%
Last trade - 00:00- IN₹3.36bn
- IN₹2.99bn
- IN₹3.33bn
- 48
- 39
- 12
- 22
Annual income statement for National Peroxide, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2023 March 31st | 2024 March 31st | |
|---|---|---|
| Period Length: | 12 M | 12 M |
| Source: | ARS | ARS |
| Standards: | IAS | IAS |
| Status: | Final | Final |
| Revenue | ||
| Total Revenue | 3,759 | 3,330 |
| Cost of Revenue | ||
| Gross Profit | 1,365 | 1,139 |
| Selling / General / Administrative Expenses | ||
| Depreciation and Amortization | ||
| Unusual Expense / Income | ||
| Other Operating Expenses | ||
| Total Operating Expenses | 3,240 | 3,147 |
| Operating Profit | 519 | 183 |
| Gain / Loss on Sale of Assets | ||
| Total Net Non Operating Interest Income / Expense | ||
| Other Net Non Operating Costs | ||
| Net Income Before Taxes | 535 | 215 |
| Provision for Income Taxes | ||
| Net Income After Taxes | 395 | 168 |
| Net Income Before Extraordinary Items | ||
| Net Income | 395 | 168 |
| Income Available to Common Shareholders Excluding Extraordinary Items | ||
| Income Available to Common Shareholders Including Extraordinary Items | ||
| Diluted Net Income | 395 | 168 |
| Diluted Weighted Average Shares | ||
| Basic EPS Including Extraordinary Items | ||
| Diluted EPS Including Extraordinary Items | ||
| Diluted EPS Excluding Extraordinary Items | ||
| Normalised Income Before Taxes | ||
| Normalised Income After Taxes | ||
| Normalised Income Available to Common Shareholders | ||
| Diluted Normalised EPS | 51.8 | 28.9 |
| Dividends per Share |